Growth Hormone Therapy in Decompensated Cirrhosis: An Open-Label, Randomized Control Trial.

Sunita KumariArka DeNaveen KalraVirendra Singh

Published in: The American journal of gastroenterology (2023)

Long-term use of GH is safe in DC and leads to improvement in malnutrition and possibly QOL. However, there is no improvement in 12-month survival (NCT03420144).

Keyphrases

growth hormone
heart failure
double blind
open label
placebo controlled
dendritic cells
phase iii
phase ii
clinical trial
stem cells
study protocol